All-In with Chamath, Jason, Sacks & Friedberg

E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, real estate, Bitcoin & more

All-In Podcast, LLC 1h 35m 58 months ago

Industry veterans, degenerate gamblers & besties Chamath Palihapitiya, Jason Calacanis, David Sacks & David Friedberg cover all things economic, tech, political, social & poker.

Website

Show Notes

Tap timecodes to jump

Follow the besties:

https://twitter.com/chamath

https://linktr.ee/calacanis

https://twitter.com/DavidSacks

https://twitter.com/friedberg

Follow the pod:

https://twitter.com/theallinpod

https://linktr.ee/allinpodcast

Show Notes:

Bestie intro, Chamath's whereabouts

Breaking down Biogen's Alzheimer's drug & the FDA's controversial approval

Billionaire space race: Is Bezos going to space too risky or a smart marketing move? How the space industry is a perfect example of effective government intervention. Can anyone dominate space?

Big Tech getting back to the office: what is the new normal for companies with thousands of employees?

Recent factors on the commercial & private real estate markets, inflation head fake

ProPublica's report on billionaire tax returns

Bitcoin toxicity, Snowflake's CEO apologizes for comments on merit & diversity

Science corner with Friedberg: Induced pluripotent stem cells & cloning

Intro Music Credit:

https://rb.gy/tppkzl

https://twitter.com/yung_spielburg

Referenced in the show:

https://www.statnews.com/2021/06/07/fda-grants-historicapproval-to-alzheimers-drug-designed-to-slow-cognitive-decline/

https://www.bloomberg.com/news/articles/2021-06-10/harvard-expert-quits-fda-panel-as-furor-over-biogen-drug-grows

https://www.instagram.com/p/CP0MSOqnYEo